Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A first-generation packaging cell line for Epstein-Barr virus-derived vectors.

H J Delecluse1, D Pich, T Hilsendegen

  • 1GSF-National Research Center for Environment and Health, Institute of Clinical Molecular Biology and Tumor Genetics, Department Gene Vectors, Marchioninistrasse 25, D-81377 Munich, Germany.

Proceedings of the National Academy of Sciences of the United States of America
|April 29, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Periprosthetic Femoral Fractures Vancouver Type B2: Revision Arthroplasty Versus Open Reduction and Internal Fixation With Locking Compression Plate.

Geriatric orthopaedic surgery & rehabilitation·2019
Same author

The effect of plant growth-promoting rhizobacteria on the phytoextraction of Cd and Zn by Brassica napus L.

International journal of phytoremediation·2016
Same author

Psychometric Properties of the German Version of the Pain Vigilance and Awareness Questionnaire (PVAQ) in Pain-Free Samples and Samples with Acute and Chronic Pain.

International journal of behavioral medicine·2016
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Tightly regulated 'all-in-one' lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy.

Gene therapy·2015
Same author

Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia.

Oncogene·2014

Researchers developed a virus-free system using Epstein-Barr virus (EBV) to package large DNA into herpesvirus particles. This method enables stable delivery and maintenance of transgenes in human B cells.

Area of Science:

  • Virology
  • Molecular Biology
  • Gene Therapy

Background:

  • Epstein-Barr virus (EBV) is a lymphotropic herpesvirus.
  • Efficient gene delivery systems are crucial for genetic research and therapies.

Purpose of the Study:

  • To create a virus-free packaging cell line for encapsidating large DNA payloads into herpesvirus particles.
  • To enable stable extrachromosomal maintenance of transgenes in human B cells.

Main Methods:

  • Construction of a packaging cell line using a modified EBV mutant lacking packaging signals.
  • Design of gene vectors capable of carrying large foreign DNA and essential cis-acting elements.
  • Demonstration of encapsidation into virus-like particles and extrachromosomal maintenance.

Related Experiment Videos

Main Results:

  • A functional virus-free packaging cell line was established.
  • Gene vectors successfully encapsulated large DNA fragments into herpesvirus particles.
  • Extrachromosomal maintenance of gene vectors in recipient cells was achieved.

Conclusions:

  • This EBV-based system provides a novel approach for delivering and stably maintaining transgenes in human B cells.
  • Despite limitations like unwanted recombination, the technology holds promise for gene therapy applications.